AGTR1 and systemic sclerosis: Autoantibodies targeting ETAR (anti-ETAR) and AT1R (anti-AT1R) have been found in patients affected by SSc, with a prevalence of 85%, showing a strong correlation with each other and a cross-reactivity for both receptors [111].